Reno-vascular hypertension Flashcards
Causes of secondary hypertension
- Endocrine: Cushing’s, Conn’s, Phaeochromocytoma, hyperthyroidism, hyperparathyroidism, adreno-genital syndrome
- Renal parenchymal disorders: Nephroblastoma
- Renovascular disorders: Renal artery stenosis, coarctation of the aorta, the middle aortic syndrome
Clinical features that suggest secondary hypertension
- Early onset of hypertension (<30 y.o)
- Late onset hypertension
- Severe hypertension (>160/100)
- Malignant hypertension (>180/120)
- Multi-drug requiring therapy for hypertension
- Medically refractory hypertension
- epigastric bruits
- Grade 3 or 4 hypertensive retinopathy
- Flash pulmonary oedema (non-cardiogenic)
- Refractory angina in the elderly
- Clinical stigmata of endocrine disorders
What does an endocrine screen entail in a patient with suspected secondary hypertension
- 9 am or midnight serum cortisol
- 24 hour urinary cortisol levels
- serum aldosterone levels
- Plasma renin assays
- 24 hour urinary metanephrines/ catecholamines
- Plasma catecholamines
- Thyroid function tests
- parathyroid hormone levels
- Serum calcium and phosphate levels
What imaging options are available based on the endocrine screen for secondary hypertension
- CT abdomen, brain or chest
- ultrasound of the thyroid gland
- Radio-isotope scans
Which renal investigations are available?
- Duplex ultrasound of the kidneys: renal masses/ tumours; discrepant renal lengths
- MAG 3 renogram with GFR
- Captopril renogram
- Vascular imaging (aortic and renal): DSA, CTA, MRA
How does angiotensin II produce hypertension
- Acts on Angiotensin II receptors resulting in vasoconstriction
- Promotes the production and release of aldosterone which results in fluid retention and volume expansion
What are the three Goldblatt models and how do they each present?
- Single renal artery stenosis (RAS)/ two kidney model: Hypertension but no volume expansion
- Bilateral RAS/ two kidney model: hypertension and volume expansion
- RAS in solitary kidney model: hypertension and volume expansion
What is ACE-I intolerance and what does it suggest?
- Patient taking ACE-I, loses vasoconstriction of the efferent arteriole, resulting in decreased glomerular pressure and subsequent filtration.
- Represents a subtle clinical clue that RAS may be cause of patient’s severe hypertension
The anatomical classification of RAS
- Ostial
- Parostial
- Truncal
- Accessory
- Segmental
- Mixed type
- Renal artery occlusion
Pathological classification of RAS
- Atherosclerotic
- non- Arthersclerotic
Causes of non-artherosclerotic RAS
- Fibromuscular dysplasia
- Takayasu’s disease
- Renal artery dissection
- Developmental (neurofibromatosis)
- Renal artery aneurysm
- Trauma
- Juxta-renal saccular aortic aneurysm
- Radiation induced RAS
- Anastomotic RAS involving transplant kidneys
What is haemodynamically significant RAS?
Has been estimated at >60% stenosis
Treatment modalities of RAS
- Medical therapy
- Percutaneous transluminal renal angioplasty
- Percutaneous transluminal renal angioplasty and stenting
- Surgical revascularisation
- Nephrectomy
Which two ways can atherosclerosis manifest?
- severe hypertension
- Ischaemic nephropathy
Clinical presentation of atherosclerotic RAS
- Elderly
- Usually with risk factors: smoking, hypertension, diabetes meillitus, hyperlipidaemia and obesity
- May have associated ischaemic heart disease, absent leg pulses or carotid bruits. May have epigastric bruit on auscultation of the abdomen
Treatment of mild- moderate atherosclerotic RAS
- Risk factor reduction
- Anti-platelet therapy
- Statins
- Anti-hypertensive treatment
- ACEIs reccommended in treatment regimens
What is the first line treatment in people with co-morbidities
Percutaneous renal angioplasty and stenting (PTRAS)
what are the surgical options for atherosclerotic RAS
- Aorto-renal bypass procedure
- Renal endarterectomy
- Extra axial bypass procedures (Hepato-renal bypass, spleno-renal artery bypass)